Stocks and Investing
Stocks and Investing
Wed, August 12, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 11, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (ADVM) at Buy with Increased Target to $210 on, Aug 11th, 2020
Mani Foroohar of SVB Leerink, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Buy with Increased Target from $200 to $210 on, Aug 11th, 2020.
Mani has made no other calls on ADVM in the last 4 months.
There are 3 other peers that have a rating on ADVM. Out of the 3 peers that are also analyzing ADVM, 0 agree with Mani's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mani
- Luca Issi of "RBC Capital" Initiated at Buy and Held Target at $240 on, Wednesday, May 13th, 2020
- Joon Lee of "SunTrust Robinson Humphrey" Upgraded from Hold to Strong Buy and Held Target at $210 on, Tuesday, May 5th, 2020
- Graig Suvannavejh of "Goldman Sachs" Initiated at Strong Buy and Held Target at $170 on, Tuesday, April 28th, 2020